|
2024
|
P/S
|
pharmaceutical preparations and vaccines for veterinary use, namely, for the treatment of ruminan... |
|
|
P/S
|
Pharmaceutical preparations for use in Oncology |
|
|
P/S
|
Pharmaceutical preparations for use in oncology |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
Invention
|
Compositions of programmed death receptor 1 (pd-1) antibodies and methods of obtaining the compos... |
|
|
Invention
|
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of... |
|
|
P/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
P/S
|
pharmaceutical preparations; human vaccine preparations providing medical information in the fiel... |
|
|
P/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
Invention
|
Methods for making polysaccharide-protein conjugates.
The present invention provides methods for... |
|
|
Invention
|
Treatment method and use of pharmaceutical combination containing conjugate. The present inventio... |
|
|
Invention
|
Treatment combination, and use thereof and treatment method. The present invention relates to a t... |
|
|
Invention
|
Combination therapies for the treatment of cancer. Provided are methods of treating a cellular pr... |
|
|
Invention
|
Combination therapies for the treatment of non-small cell lung cancer. Provided are methods of tr... |
|
|
Invention
|
Processes for preparing soluble guanylate cyclase stimulators. The invention relates a processes ... |
|
|
Invention
|
Processes for preparing crystalline soluble guanylate cyclase stimulators. The invention relates ... |
|
|
Invention
|
Inhibitors of human respiratory syncytial virus and metapneumovirus. The present disclosure is di... |
|
|
Invention
|
Use of a long-acting oxyntomodulin derivative for treament of fatty liver disease. The use of a l... |
|
|
Invention
|
Passive permeable pcsk9 antagonist compounds. Compounds of Formula (I), or a pharmaceutically acc... |
|
|
Invention
|
Chimeric antigen receptors and use thereof. The present disclosure provides CARs comprising a hum... |
|
|
Invention
|
Methods of using cyclic peptides for trapping interleukin-1 beta. Provided are methods of using a... |
|
|
Invention
|
Antimalarial agents. The present disclosure is directed to compounds of Formula I: (I) and method... |
|
|
Invention
|
Nanoemulsion adjuvant compositions for human papillomavirus vaccines. The present disclosure prov... |
|
|
Invention
|
Nanoemulsion adjuvant compositions for human papillomavirus vaccines.
The present disclosure pro... |
|
|
Invention
|
Data processing method, system, and apparatus for high resolution mass spectrometry. A system and... |
|
|
Invention
|
5,6 unsaturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3.
Novel ... |
|
|
Invention
|
5,6 unsaturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3. Novel c... |
|
|
Invention
|
5,6 saturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3. Novel com... |
|
|
Invention
|
Compounds and adjuvant formulations useful in pneumococcal vaccines.
The invention relates to no... |
|
|
Invention
|
Compounds and adjuvant formulations useful in pneumococcal vaccines. The invention relates to nov... |
|
|
Invention
|
Compounds and formulations useful as vaccine adjuvants. The invention relates to novel compounds ... |
|
|
P/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
|
Invention
|
Methods of improving lung diffusion capacity in a patient with pulmonary arterial hypertension. T... |
|
|
Invention
|
Small molecule inhibitors of kras g12d mutant. Compounds or their pharmaceutically acceptable sal... |
|
|
Invention
|
Polynucleotides encoding norovirus vp1 antigens and uses thereof.
The present invention is direc... |
|
|
Invention
|
Polynucleotides encoding norovirus vp1 antigens and uses thereof. The present invention is direct... |
|
|
Invention
|
Cyclic peptides as pet imaging agents of granzyme b. Disclosed are cyclic peptides, their salts, ... |
|
|
Invention
|
Streptococcus pneumoniae serotype specific pcr pad assay.
The invention described herein relates... |
|
|
Invention
|
Delivery devices for anti-hiv compounds. Drug delivery devices comprising a microneedle patch, or... |
|
|
Invention
|
Trop2 binders and conjugates thereof.
TROP2 binders and variants thereof are described. In a spe... |
|
|
Invention
|
Trop2 binders and conjugates thereof. TROP2 binders and variants thereof are described. In a spec... |
|
|
Invention
|
Anti-trop2 antibody-drug conjugates comprising pnu-159682 derivatives. Anti-TROP2 antibody-drug c... |
|
|
Invention
|
Evaluating production batches using machine-learning.
A method or a system for automated product... |
|
|
Invention
|
A cyclic peptide for trapping interleukin-1 beta. Provided are compounds of the Formula (I), or t... |
|
|
Invention
|
Streptococcus pneumoniae serotype-specific detection assay, reagents and kits.
S. pneumoniae is ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
|
Invention
|
Modified short interfering nucleic acid (sina) molecules and uses thereof.
Disclosed herein are ... |
|
2023
|
P/S
|
Providing medical information relating to cancer Personal support services for cancer patients, n... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
|
P/S
|
Human vaccine preparations |
|
|
Invention
|
Antimalaria agents. The present disclosure is directed to compounds of Formula (I): and methods o... |
|
2022
|
Invention
|
Glucose-responsive insulin conjugates comprising a tetra-valent sugar cluster for treatment of di... |
|
|
Invention
|
Vial-to-syringe converter and methods of making and using same.
In some examples, a vial-to-syri... |
|
|
Invention
|
Microneedle injector and methods of making and using same.
In some examples, an injector include... |
|
|
Invention
|
Spirotricycle ripk1 inhibitors and methods of uses thereof.
Described herein are compounds of Fo... |
|
|
Invention
|
Benzoxazinone derivatives as selective cytotoxic agents.
The present disclosure is directed to b... |
|
|
Invention
|
Tricyclic sulfamides and sultams.
Compounds of formula I, that modulate DCAF15 and induce RBM139... |
|
|
Invention
|
C-linked isoquinoline amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof. ... |
|
|
Invention
|
Allosteric modulators of nicotinic acetylcholine receptors.
The present disclosure relates to co... |
|
|
Invention
|
Syringes and injectors with capacitive sensing locks and methods of making and using same.
An in... |
|
|
Invention
|
Method for analyzing trace levels of semi-volatile nitrosamines in solid samples.
This invention... |
